Scott Alan Peslak, MD, PhD
Hematology
Headshot of Scott Alan Peslak, MD, PhD

Scott Alan Peslak, MD, PhD

he/him/his
Hematology
Accepting new patients
Sees patients age 18 and up
Penn Blood Disorders Center
Headshot of Scott Alan Peslak, MD, PhD
Penn Medicine Provider

About me

  • Gene Therapy Lead, Comprehensive Sickle Cell Program and Comprehensive Adult Thalassemia Program
  • Assistant Professor of Medicine (Hematology-Oncology)
  • Assistant Professor of Pediatrics

I am a physician-scientist at the University of Pennsylvania and I care for patients in the Penn Medicine Comprehensive Sickle Cell Disease Program and Comprehensive Adult Thalassemia Program. In addition to my clinical focus on red cell disorders, I also run a laboratory studying novel regulators of fetal hemoglobin and new genetic and pharmacologic therapies for the treatment of sickle cell disease.

My education and training

  • University of Rochester School of MedicineMedical School
  • University of Pennsylvania Health SystemResidency
  • University of Pennsylvania Health SystemFellowship

Spoken languages

English
English

Reviews

Average Rating

92 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
All good.
Anonymous
August 2026
provider's knowledge, time spent together, listening
Anonymous
June 2026
very good
Anonymous
May 2026
great clinician

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Peslak is a Penn Medicine provider.

Qualifications and experience

All conditions and treatments

Research

Publications

Peslak, S.A. IGF2BP1: A Double Agent in Hemoglobin Switching , Blood, 148(13): 2026


Cheng, A.N., Peslak, S.A., Sheth, S., Sayani, F.A., Lal, A. Delayed Recognition and Significant Morbidity in Adults with Non-Transfusion-Dependent Thalassemia , Blood Advances, 10(18): 2026,6051-6059


Sheth, S., Lal, A., Appiah-Kubi, A., Peslak, S.A., Temin, N.T., Chen, A.M., and Coates, T. Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias , Blood Advances, 10(17): 2026,5886-5898


Al Ta’ani, O., Mayrer, B.M., Luche, N.M., Siddique, S.M., Peslak, S.A., Anderson, T.S., Vajravelu, R.K. Distribution of Gastrointestinal and Dietary Risk Factors Among U.S. Adults Classified as Having Iron Deficiency Anemia Across Diagnostic Thresholds , American Journal of Hematology, 101(8): 2026,2095-2099


Cheng, A.N., Cohen, J., Lundberg, R.K., Sayani, F.A., Chong, E.A., Peslak, S.A. Beyond Hypersplenism: Splenic Marginal Zone Lymphoma in an Older Adult with Hemoglobin E/Beta-Thalassemia , Hemoglobin, 50(3): 2026,288-292


Traxler, E.A., Hotan, Q., Shao, Y., Komar, C., Chen, Q., Saari, M.S., Thrasher, A.J., Yang, S., Qin, K. Wang, M., Peslak, S.A., Abdulmalik, O., Giardine, B.M., Keller, C.A., Hardison, R.C., Minn, A.J., Khandros, E., Shi, J., Blobel, G.A. Optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing. , Blood: 2026


Castracani C.C., Bright M., Patel J., Peslak S.A., Cheng A., Breda L., Rivella S., Kwiatkowski J. Real-world comparative effects of curative and disease-modifying therapies on ineffective erythropoiesis in beta-thalassemia , American Society of Hematology Annual Meeting, Orlando, FL: 2025


Cheng A.N., Gimotty P., Margolis D., Peslak S.A., Al-Samkari H, Roe A.H., Kwiatkowski J.L. Development of a Prediction Model for Maternal Pregnancy Complications in Sickle Cell Disease , American Society of Hematology Annual Meeting, Orlando, FL: 2025


Al Ta’ani, O.; Mayrer, B.M.; Luche, N.M.; Siddique, S.M., Peslak, S.A.; Anderson, T.S.; Vajravelu, R.K. Impact of Diagnostic Serum Ferritin Thresholds on Prevalence of Iron Deficiency Anemia: A Cross-Sectional Analysis of U.S. Adults , JAMA Internal Medicine, Online Ahead of Print: 2025,e252311


Huang, P., Peslak, S.A., Shehu, V., Keller, C.A., Giardine, B., Shi, J., Hardison, R.C., Blobel, G.A., Khandros, E. Let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching , Blood, 143(19): 2024,1980-1991


View all publications